Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Title||A Phase 3 Extension Study of IPI-145 and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07|
|Sponsors||Infinity Pharmaceuticals, Inc.|
|Covered Countries||USA | ITA | FRA | ESP | DEU | BEL | AUT|